The Programme

Registration

Opening remarks from the Chair

Keith Allen
Production Support Team Leader
GlaxoSmithKline

Implementing new packaging initiatives to ensure product differentiation

• What innovative packaging really is and how to achieve it
• Packaging developments for new markets and products
• Considering market specifics and implementing these into new P&L processes

Blister packaging – a practical insight

• Insight into a complex operation with multiple global SKU’s
• Strategic and tactical initiatives to meet customer and regulatory demands
• Challenges for the future

Developments in the packaging of pre-filled syringes

• The requirements of the package
• Focus on packaging costs cardboard versus pvc
• Protection from counterfeiting and tamper-evident seals
• Energy and environmental factors 

Morning refreshments

Assessing the latest labelling requirements and managing different labelling needs in trials

• Positioning clinical supplies
• Collaborating effectively with the clinical study team
• Labelling requirements for IMP
• Different labelling needs for different stakeholders

MHRA anti-counterfeiting strategy and supply chain guidance

• Counterfeit medicines - the facts and trends with a focus on counterfeit packaging
• MHRA’s anti-counterfeiting strategy
• Communication,collaboration andregulation
• Supply chain guidance
• Case overview – largest UK counterfeit medicines penetration 2007

Lunch

Breakthrough solutions for pharma brand authentication and security

• Enhancing pharma supply chain security – assessment of current preferred technologies
• Harmonising product identification and product security in real time – what is the best solution?
• The breakthrough – next generation of secure, flexible and cost-effective anti-counterfeiting technology

Thermoforming films revisited: enhancing patient compliance and
reducing cost

• Producing pack presentations that enhance patient adherence and persistence to therapies
• Assisting total cost savings over the full life-time of a drug
• Discussing the strategic benefits of thermoformed packaging

Klaus Menges
Head, Scientific Quality Assurance,
FEDERAL INSTITUTE FOR DRUG AND MEDICAL DEVICES (BfArM)

Addressing the challenges of readability testing on PILs

• Identifying the key issues in PIL user testing
• Assessing the best techniques
• Implementing efficient methods

Afternoon refreshments

Using design to maximise patient safety through improved readability of Patient Leaflets and Packaging

• Consider global templates to convey information more effectively on patient leaflets
• Ensure packs are clearly marked with safety instructions
• Enabling an effective testing strategy  

Bruce Warner
Senior Pharmacist
National Patient Safety Agency

A United Kingdom view of designing for patient safety

• The effect of design on safe medication practice
• Recap on the the Council of Europe Safe Medication Practice Report
• The importance of ‘Purchasing for Safety’ initiatives
• Design for Patient Safety Initiatives at the NPSA

Raising the bar on patient safety and efficiency - global standards in the healthcare supply chain

• Identifying packaging and labeling challenges for product identification and traceability
• Regulatory and technology trends
• Need for global harmonisation based on global and open standards

Closing remarks from the Chair and end of Day One

Child resistant packaging – delivering child safety and simultaneously exceeding the forthcoming standard for adult open-ability

• Examining the newly proposed CEN standards for open-ability of packaging
• Discussing the results and interferences of a case study on CR packs testing under these standards
• Describing design criteria which contribute to ease of opening
• Discussing the impact of environmental constrains
• Identifying opportunities to add value

John Gill
Chief Scientist
Royal National Institute of Blind People (RNIB)

• The problems imposed by visual impairment
• Inclusive design for labelling
• Adding Braille to packaging
• Patient information leaflets in alternative formats

• The medicalisation of society
• Adherence – the key to outcomes
• How pack design can help patients follow their regimen
• The benefit of adherence-supporting packaging to the pharma industry

Examining artwork management systems

• Identifying the challenges of artwork management
• Increasing quality and efficiency in artwork processes
• The future of artwork management